CrushSCI.com
120.6Average days
91.5Median days
30Fastest days
226Longest days
4532025 publications

Paper Review Records

All Paper Review Records

10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

81 days

Impact of cumulative glucocorticoid exposure on vancomycin clearance in hospitalized children: A retrospective cohort study

Authors
Kouki Tomari; Ruud H. J. Verstegen; Cintia Cruz; Erin Chung; Aleena Azim; Shinya Ito; Tamorah R. LewisShow moreShow less
Affiliations
1. Division of Clinical Pharmacology & Toxicology The Hospital for Sick Children Toronto Ontario Canada; 2. Department of Paediatrics University of Toronto Toronto Ontario Canada; 3. Division of Rheumatology The Hospital for Sick Children Toronto Ontario Canada; 4. Department of Pharmacy The Hospital for Sick Children Toronto Ontario Canada; 5. Graduate Department of Pharmaceutical Sciences University of Toronto Toronto Ontario Canada; 6. Child Health Evaluative Services The SickKids Research Institute Toronto Ontario Canada; 7. Faculty of Arts & Science University of Toronto Toronto Ontario Canada; 8. Translational Medicine, Research Institute Hospital for Sick Children Toronto Ontario CanadaShow moreShow less
Official full-text evidence DOI Publisher page
80 days

A descriptive case series of hepatotoxicity associated with CFTR modulators and possible relevance of pharmacogenetic polymorphisms in cystic fibrosis patients

Authors
Clara Laffitte Redondo; Venceslas Bourdin; Abd El Kader Ait Tayeb; Sihem Benaboud; Inès Martins; Caroline Joyau; Myriam Benhamida; Isabelle Sermet‐Gaudelus; Clémence Martin; Pierre Régis Burgel; Céline Verstuyft; Laurent Chouchana; Estelle Ayme‐DietrichShow moreShow less
Affiliations
1. Service de Médecine Génomique et Pharmacogénomique CHU Kremlin Bicêtre, APHP Paris France; 2. Centre Régional de Pharmacovigilance, Service de Pharmacologie, Hôpital Cochin, AP‐HP, Université de Paris; Réseau Français de Pharmacovigilance Paris France; 3. Service de Pharmacologie Clinique Hôpital Cochin, AP‐HP, Université de Paris‐Cité Paris France; 4. Centre Régional de Pharmacovigilance, Service de Pharmacologie Clinique, Institut de Biologie CHU Hôtel Dieu Nantes France; 5. Centre de Ressources et de Compétence pour la Mucoviscidose Hôpital Mère‐Enfant Nantes France; 6. INSERM U1151, Université Paris Cité, Hôpital Necker Enfants Malades, APHP Paris France; 7. Institut Cochin, Université Paris Cité, Inserm U1016 Paris France; 8. Université Paris Cité Inserm UMR‐S 1343, Pharmacologie et évaluations des thérapeutiques chez l'enfant et la femme enceinte Paris France; 9. Laboratoire de Pharmacologie et Toxicologie NeuroCardiovasculaire, UR7296, Hôpitaux Universitaires de Strasbourg Université de Strasbourg Strasbourg FranceShow moreShow less
Official full-text evidence DOI Publisher page
62 days

Codeine toxicity via breast Milk: Can this occur and implications for opiate therapy in children

Authors
Michael RiederShow moreShow less
Affiliations
1. Departments of Paediatrics, Physiology & Pharmacology and Medicine University of Western Ontario London Ontario Canada; 2. Division of Paediatric Clinical Pharmacology, Department of Paediatrics Children's Hospital of Western Ontario London Ontario CanadaShow moreShow less
Official full-text evidence DOI Publisher page
150 days

Effect of esomeprazole on the pharmacokinetics of vepdegestrant, a PROteolysis TArgeting Chimera oestrogen receptor degrader, in healthy participants

Authors
Lana Tran; Naihan Chen; Jennifer A. Winton; Kyle T. Matschke; Smita P. Goodman; Kimberly C. Lee; Yuanyuan Zhang; Weiwei TanShow moreShow less
Affiliations
1. Pfizer, Inc San Diego California USA; 2. Pfizer (China) R&D Co, Ltd Shanghai China; 3. Pfizer, Inc. Groton Connecticut USA; 4. Pfizer, Inc. Collegeville Pennsylvania USA; 5. Pfizer, Inc. New York New York USA; 6. Arvinas Operations, Inc. New Haven Connecticut USAShow moreShow less
Official full-text evidence DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.